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Abstract
Background: Recent development of novel technologies paved the way for quantitative proteomics. One of the
most important among them is iTRAQ, employing isobaric tags for relative or absolute quantitation. Despite large
progress in technology development, still many challenges remain for derivation and interpretation of quantitative
results. One of these challenges is the consistent assignment of peptides to proteins.
Results: We have developed Peptide Profiling Guided Identification of Proteins (PPINGUIN), a statistical analysis
workflow for iTRAQ data addressing the problem of ambiguous peptide quantitations. Motivated by the
assumption that peptides uniquely derived from the same protein are correlated, our method employs clustering
as a very early step in data processing prior to protein inference. Our method increases experimental
reproducibility and decreases variability of quantitations of peptides assigned to the same protein. Giving further
support to our method, application to a type 2 diabetes dataset identifies a list of protein candidates that is in very
good agreement with previously performed transcriptomics meta analysis. Making use of quantitative properties of
signal patterns identified, PPINGUIN can reveal new isoform candidates.
Conclusions: Regarding the increasing importance of quantitative proteomics we think that this method will be
useful in practical applications like model fitting or functional enrichment analysis. We recommend to use this
method if quantitation is a major objective of research.
Background
Quantitative proteomics is becoming increasingly impor-
tant and over the last years many efforts have been made
to develop and improve methods allowing for protein
quantification. Besides gel based approaches [1,2], mass
spectral techniques encompassing labeling techniques
such as iTRAQ [3], ICAT [4] and SILAC [5,6] as well as
label free approaches are widely-used for quantitative
proteomics. Especially iTRAQ (isobaric tags for relative
and absolute quantitation) gained much popularity as it
allows for multiplexing quantitation of up to 8 samples.
This new flexibility has been used recently in several stu-
dies investigating various objectives [7-11].
Complementing these experimental technologies, a
wide range of quantification algorithms can be found in
the literature. The most common algorithms are included
in software packages such as MASCOT, ProQUANT,
i-TRACKER [12,13], Multi-Q [14] or virtual expert mass
spectrometrist (VEMS) [15]. In 2008 Lacerda et al. [16]
compared the two software packages MASCOT and
Peaks (Bioinformatics Solutions Inc., Waterloo, ON,
Canada) [17] using a six-protein mixture as well as a
complex protein sample. They revealed significant differ-
ences in the two packages as for a complex protein mix-
ture only 26% of the proteins agreed within 20% error of
quantitation ratios. The highest fold changes measured
with iTRAQ differ widely among laboratories but rarely
seem to exceed ten-fold, which was reported by Casado-
Vela et al. [18] in a technical survey examining more
than 200 articles.
The continuing popularity of iTRAQ makes an evalua-
tion of the technique in terms of accuracy and precision a
valuable task [19]. Accuracy assesses the closeness to the
real quantification value. Precision in this context refers to
reproducibility of experiments. Since accuracy is difficult
to evaluate, precision is the most frequently applied mea-
sure for experimental quality [20,21]. Gan et al. [22] tried
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cal (different channels of the same MS run), experimental
(same channel but different runs) and biological variations
(different biological samples). They designed different
iTRAQ experiments covering the different types of repli-
cations and they found technical variation to be small
(11%) whereas experimental and biological variations
where more than twice as high. For iTRAQ - like for the
majority of MS based quantitation approaches - quantita-
tion measurements are performed at the peptide level.
Since often multiple peptides potentially with different
modifications are measured for the same protein, the need
for some kind of summarizing strategy is obvious. Differ-
ent ideas regarding the calculation of protein quantitation
from multiple peptides have been applied including mean
or median calculation [23,24] and error weighted means
[25]. Because of the fixed stoichiometric ratio, quantitation
measurements for peptides uniquely assigned to the same
protein should be strictly correlated [26]. But often this
presumption is not fulfilled and the quantitation values
exhibit a substantial heterogeneity. The heterogeneity is
also observed for quantitation ratios and z-transformed
values and is not due to different ionization or fragmenta-
tion efficiency. This is illustrated in Figure 1 presenting
the quantitation ratios of unique peptides for an exemp-
lary chosen protein: 40S ribosomal protein S30. Especially
the 117/116 ratio (rightmost bar in Figure 1) varies from
1.4 fold down-regulation to 2 fold up-regulation. An
obvious reason for heterogeneous quantitation values are
non-unique peptides shared by different proteins.
To correct for heterogeneity of peptides for the same
protein, many approaches make use of outlier detection
methods like Grubb’st e s t[ 2 3 ]o rD i x o n ’s test [25] prior
to averaging. However, for several reasons outlier filters
are problematic: First, outlier filtering can be applied
only to proteins with a certain minimum number of
peptides, a presumption often not fulfilled in iTRAQ
datasets [27]. Second, if heterogeneity is due to differen-
tially regulated protein isoforms, the less frequent iso-
form is possibly regarded as an outlier and removed
leading to loss of information. Third, if outlier detection
is applied after protein inference, false positive peptides
are removed that contributed to the protein identifica-
tion score and hence the score is distorted a posteriori.
Here we present a statistical analysis workflow for
iTRAQ data employing clustering prior to protein infer-
ence with the aim to reduce peptide heterogeneity (see
Figure 2).
Methods
Dataset
Liver tissue samples from two different inbred mouse
strains were investigated. The New Zealand Obese
(NZO) mouse strain exhibits a polygenic obesity
associated with hyperinsulinaemia and hyperglycaemia
and presents additional features of a metabolic syn-
drome, including hypertension, and elevated levels of
serum cholesterol and serum triglycerides [28]. In con-
trast, the Swiss Jim Lambert (SJL) mouse strain is lean
and resistant to diet-induced obesity [29]. SJL mice
carry a naturally occurring loss-of-function mutation in
the TBC1D1 gene that confers leanness and protects
from diet-induced obesity and diabetes [30]. In fact,
deletion of TBC1D1 leads to elevated lipid oxidation in
skeletal muscle that prevents weight gain in response to
a high fat diet. Conversely, NZO mice are highly suscep-
tible to weight gain when fed a high-fat diet, resulting in
the development of morbid obesity, with fat depots
exceeding 40% of total body weight [31].
After weaning at week 3, male NZO and SJL mice
were raised on two different diets, a low fat diet (SD;
16% calories from fat) and a high fat diet (HF; 35% cal-
ories from fat). At week 12, mean body weight of SJL
mice was 18.99 g (+/- 1.41 g) on SD and 20.1 g (+/-
1.42 g) on HF. In contrast, mean values for NZO mice
were 38.81 g (+/- 1.85 g) on SD and 56.52 g (+/- 3.45 g)
on HF, respectively. The mice were then sacrificed and
liver tissue samples were analyzed.
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Figure 1 Peptide Heterogeneity.E x e m p l a r yc h o s e np r o t e i n
accession 40S ribosomal protein S30 (RS_30) for demonstration of
peptide heterogeneity. Every line represents a unique peptide
profile (peptide-spectrum-match) identified as originating from the
RS_30 protein. iTRAQ ratios are calculated using 116 channel (SJL
mouse with standard diet) as reference. For every ratio a box plot
giving the lower quartile, median and upper quartile is drawn.
Especially for the 117/116 ratio (NZO mouse with high fat diet) the
quantitation ratios are very heterogeneous ranging from -0.5 to +1
(corresponding to a 1.4 fold down-regulation or 2 fold up-
regulation).
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Page 2 of 12Animals were kept in accordance with the NIH guide-
lines for the care and use of laboratory animals and all
experiments were approved by the Ethics Committee of
the State Ministry of Agriculture, Nutrition and For-
estry, State of Brandenburg, Germany (23-2347-8-19-
2008). Three to six mice per cage (macrolon type III)
were housed at a temperature of 22°C and a 12 h light-
dark cycle (lights on at 6 a.m.). Throughout the study
the animals had free access to food and water.
Experimental design and iTRAQ labeling strategy are
shown in Table 1. Three experimental replications were
performed for each combination of genotype and diet.
Experimental replications comprises a total of twelve
different mouse individuals and four different iTRAQ
channels (see Table 1). Due to this experimental design,
the measured variance for each combination of genotype
and diet is a superposition of technical (different iTRAQ
channels) and biological error (different mouse indivi-
duals). This design was chosen to match real-life experi-
ments where these errors are important.
The dataset (Mascot Generic Files - mgf) was uploaded
to PRIDE [32] - Accession number: 20140.
MASCOT
Peptide identification and quantitation were performed
using MASCOT search engine (version 2.2.04 Matrix
Figure 2 Workflow. Standard workflow of proteomics data evaluation (left hand side) compared to the PPINGUIN workflow presented in our
manuscript (right hand side). Starting point for both workflows is the mzML [48] file containing the spectral peak data. In contrast to the
standard workflow we employ clustering as a very early step prior to protein inference. This leads to splitting of spectra into different groups.
Quantitation and identification is performed independently for each group. The result is a list of identified and quantified proteins ready for
downstream analysis.
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Page 3 of 12Science, London). Peptides identified with a MASCOT
score < 50 and a significance threshold of p > 0.05 were
neglected. Searches were performed using the following
parameter set: Enzyme: Trypsin; maximum missed clea-
vages: 2; fixed modification s :M e t h y l t h i o( C ) ,i T R A Q 4 -
plex (N-term), iTRAQ4plex (K); quantitation method:
iTRAQ 4 plex with weighted protein ratio and median
normalization of ratios; variable modifications: Oxida-
tion (M), iTRAQ4plex (Y); peptide mass tolerance: 10
ppm; fragment mass tolerance: 0.8 Da; mass values:
monoisotopic; instrument type: ESI-FTICR; Isotope
error mode: 0; minimum of 1 peptide per protein
identification.
The database used was a SwissProt derived FGCZ in-
house mouse database from 2009 containing 43636
mouse protein sequences (OS = Mus musculus) and 259
additional FGCZ specific entries. All proteins are pre-
sent in normal/forward sequences and decoy/reverse
sequences. Randomized decoy database (reversed
sequences) was used for controlling false discovery rate
(FDR) [33,34]. For calculation of FDR the list of proteins
ordered by MASCOT ProtScore was cut when given
FDR level was reached. Because we intend to achieve
reliable quantitation results rather than provide a com-
prehensive protein list, the false discovery rate was cho-
sen restrictively: FDR = 0.1%.
X!Tandem and OpenMS
Peptide identification was performed using X!Tandem
software (http://www.thegpm.org/tandem) [35] version
2009.04.01.1. X!Tandem search was performed using the
following parameter set: cleavage site: ‘[RK]|P’; precur-
sor-charge: 2; missed-cleavages: 2; fragment-mass-toler-
ance: 0.8 Da; precursor-mass-tolerance: 10 ppm; fixed-
modifications: iTRAQ4plex (N-term), iTRAQ4plex (K),
Methylthio (C); variable-modifications: Oxidation (M),
iTRAQ4plex (Y); refinement of unanticipated cleavages.
Extraction of 4-plex iTRAQ quantitation data and iso-
tope correction was performed using OpenMS (http://
open-ms.sourceforge.net) [36,37] svn revision 6265. The
same decoy database as for MASCOT analysis was used
and again false discovery rate was chosen restrictively:
FDR = 0.1%. For calculation of FDR the list of proteins
ordered by X!Tandem protein identification score was
cut when a given FDR level was reached.
Peptide Profiling Guided Identification of Proteins -
PPINGUIN
We define an iTRAQ quantitation profile of a spectrum
as the ordered list of the raw quantitation values, in our
case the raw intensities of the four iTRAQ channels 114
to 117. PPINGUIN seizes on the presumption that pro-
files of peptides derived from the same protein are
highly correlated as they have a common source. As a
first step and thus without regarding protein inference,
iTRAQ quantitation profiles of the spectra are calcu-
lated by extracting the four quantitation values using
OpenMS. In this prove of concept study, we want to
show that clustering based on quantitation profiles
representing different experimental conditions can help
to correctly quantify proteins. In order to avoid distor-
tions by missing values, we restrict the analysis to spec-
tra with complete quantitation profiles and remove
spectra with incomplete profiles. The recommended iso-
tope correction is performed according to manufac-
turer’s specifications (Applied Biosystems, Foster City,
CA) using OpenMS. Isotope correction aims at correct-
ing for trace levels of isotopic impurities and is done by
solving a system of equations. In addition a complemen-
tary normalization of the four quantitation values is per-
formed as described below.
Logarithmic quantitation profiles of the spectra are
clustered in a coarse-grained manner using k-means
algorithm [38] based on Euclidean distance and ran-
domly selected starting points. We use k-means cluster-
ing (k = 5) as it is computationally fast and well suited
to demonstrate the benefit of the pre-selection. The
group size parameter k = 5 was chosen according to
two internal cluster validation measures (see Section
‘Number of Clusters’). To analyze stability of the cluster-
ing, it was performed for 1000 replications each with
different randomly chosen starting points. From 1000
iterations 999 resulted in the same or a very similar par-
titioning of the quantitation profiles of the spectra.
Clustering intends to create groups of peptides with
similar biological profiles (e.g. up-regulation for a cer-
tain combination of genotype and diet). As subsequent
analysis is focused on relative iTRAQ ratios instead of
absolute quantitation values and Euclidean distance is
not scale independent, the profiles are centered prior to
clustering (mean is set to zero). Euclidean distance used
Table 1 Experimental Design
NZO_SD NZO_HF SJL_SD SJL_HF
Exp 1 mouse:1 - channel:114 mouse:4 - channel:117 mouse:7 - channel:116 mouse:10 - channel:115
Exp 2 mouse:2 - channel:115 mouse:5 - channel:114 mouse:8 - channel:116 mouse:11 - channel:117
Exp 3 mouse:3 - channel:116 mouse:6 - channel:115 mouse:9 - channel:117 mouse:12 - channel:114
Experimental design and iTRAQ labeling (114 - 117) for three experimental replications (Exp 1, Exp 2 and Exp 3). For every distinct combination of genotype and
diet 3 different mouse individuals are used.
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In order to preserve differences between relative iTRAQ
ratios no additional scaling was performed (standard
deviation is preserved). This procedure equals to a clus-
tering using Euclidean distances on centered logarithmic
quantitation profiles. With this procedure an explicit
choice of a reference channel is not necessary. Every
spectrum is assigned to exactly one group and for every
group the corresponding spectra show similar quantita-
tion profiles. Quantitation and identification is now per-
formed independently for every group with identical
settings to X!Tandem and OpenMS approach. Similar to
the X!Tandem/OpenMS approach, FDR was calculated
by cutting the list of proteins ordered by X!Tandem pro-
tein identification score if a given FDR level was
reached. The FDR is calibrated for each group individu-
ally and in effect, X!Tandem threshold for protein iden-
tification differs in each group. Finally, log2 ratio profiles
are calculated using SJL genotype with standard diet
(SD) as reference. Following the definition of iTRAQ
quantitation profiles, ratio profiles are defined as the list
of 3 possible iTRAQ ratios (e.g. for Exp 1: 114/116, 115/
116 and 117/116 - see Figure 1).
All calculations (normalization and clustering) were
performed using R statistical programming language (R
version 2.7.0 - 2008-04-22). The R-script of our imple-
mentation of PPINGUIN is provided as Additional File 1.
Protein inference and extraction of quantitation values
was performed using X!Tandem and OpenMS as
described previously.
Normalizing iTRAQ quantitations
Additional normalization of the 4 quantitation values is
required to correct for technical bias [19]. Karp et al. [27]
observed a heterogeneity of variance for iTRAQ ratios
where the width of the distribution is significantly larger
at low intensities. They proposed a variance stabilizing
normalization based on VSN software [39]. We com-
pared three different normalization strategies: VSN, multi
lowess algorithm - a multi dimensional extension of low-
ess normalization strategy [40] and median correction. In
our dataset we see heterogeneity of variance for unnor-
malized data as well as for median corrected data. The
other two normalization approaches lead to an almost
constant variance (see Additional File 2 for more details).
We selected multi-lowess as our preferred normalization
strategy.
Number of Clusters
The number of clusters is an important parameter for
clustering. The preferable number of clusters was deter-
mined using two different internal measures: gap statis-
tic [41,42] and Xie-Beni index [43]. Both measures were
calculated for 25 repetitions of runs. The preferable
number of clusters was determined to be in the range
between 3 and 7. Therefore, we selected 5 as a reason-
able number of clusters.
Calculation of CV values for Peptide Homogeneity
Let yj,r be the relative quantitation ratio for a peptide j
and ratio r Î R = {NZO_SD/SJL_SD, NZO_HFD/
S J L _ S Da n dS J L _ H F D / S J L _ S D} .T oa s s e s sp e p t i d e
homogeneity, we calculate the coefficient of variation of
a protein p by using all unique peptides for proteins:
CVp =
1
3 ∗ np

j∈p

r∈R
σj,r
μj,r
where np is the number of unique peptides for protein
pa n dsj,r and μj,r are the standard deviation and mean
of relative quantitation ratios yi,r of all peptides uniquely
assigned to protein p. The final coefficient of variation
is calculated by averaging CVp for all proteins.
Calculation of CV values for Experimental Reproducibility
Let ye,i,r be the relative quantitation ratio for experiment
e Î { E x p 1 ,E x p 2 ,E x p 3 } ,p r o t e i ni Î I =1 . . n and ratio r
Î R = { NZO_SD/SJL_SD, NZO_HFD/SJL_SD and
SJL_HFD/SJL_SD }. In order to assess experimental
reproducibility of r we calculate the average CV of all
proteins occurring in all three experiments:
CVr =
1
n
·

i∈I

σi,r
μi,r

where si,r and μi,r are the standard deviation and
mean of relative quantitation ratios yi,r for protein i and
ratio r for all three experiments:
μi,r =
1
3

e∈E
ye,i,r
σi,r =

1
2

e∈E
(ye,i,r − μi,r)
2
This value is reported in Table 2 together with mean
standard deviation of log2 ratios:
StDevr =
1
n
·

i∈I
(ˆ σi,r)
where ˆ σi,r is the standard deviation of log2 ratios:
ˆ μi,r =
1
3

e∈E
log2(ye,i,r)
ˆ σi,r =

1
2

e∈E
(log2(ye,i,r) −ˆ μi,r)
2
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We present a novel workflow termed Peptide Profiling
Guided Identification of Proteins (PPINGUIN). PPIN-
GUIN proceeds by first clustering spectra based on their
quantitation values and than inferencing proteins for
each cluster independently (see Methods). The results of
our approach are compared with standard evaluation
approaches using MASCOT and X!Tandem/OpenMS
software (see Methods).
Proteins identified
The numbers of protein accessions identified with the
same FDR (see Methods) differ for each method: 225 for
MASCOT, 177 for X!Tandem and OpenMS based
approach and 176 for PPINGUIN. Ambiguous protein
groups (e.g. H2B1B, H2B1C, H2B1F,...) identified with
exclusively non-unique peptides, were not counted here.
Therefore, the actual number of proteins and the overlaps
of the three methods may be underestimated. Most of the
representative accessions received from PPINGUIN analy-
sis were also detected using X!Tandem (83%). Both meth-
o d sh a v et h e i rs e to fu n i q u ep r o t e i n s :3 2f o rP P I N G U I N
and 33 for X!Tandem. The overlap between MASCOT
and the other two approaches is good: 70% of the X!Tan-
dem IDs and 62% of PPINGUIN IDs were found with
MASCOT (see Venn diagram in Figure 3). Explanations
for these differences are provided in the discussion below.
The quality of the three methods is assessed in terms of
three different criteria: (i) homogeneity of peptide profiles
(ii) reproducibility in independent experiments and (iii)
accordance with prior knowledge.
Homogeneity of peptide profiles
As described above, a protein represented by multiple
unique peptides should result in strictly correlated quan-
titation ratios for the peptides. But often heterogeneous
ratio profiles are observed using MASCOT as well as X!
Tandem, naturally leading to difficulties in quantitative
interpretation. This situation is illustrated in the first and
second row of Figure 4 for three example proteins. An
obvious reason for heterogeneous quantitation values are
non-unique peptides shared by different proteins. For
avoiding this fact non-unique peptides are left out for all
plots and statistical assessments. Using our approach,
peptide profiles are more homogeneous supporting a
consistent quantitative interpretation (see bottom row of
Figure 4). A distinctive feature of PPINGUIN is demon-
strated by the ribosomal protein RS_30: inconsistent
quantitation profiles are resolved by splitting up in two
groups each with homogeneous profiles. This effect is
illustrated in more detail in Figure 5 (and as addition
examples in Additional File 3). The protein is identified
in two different clusters (1 and 4) with different peptide
profiles. The peptides in cluster 1 show low relative con-
centration for NZO_SD (114) and high relative
Table 2 Experimental Reproducibility
Ratio MASCOT X!Tandem/OpenMS PPINGUIN
NZO_SD/SJL_SD 0.13 0.12 0.10
CV NZO_HFD/SJL_SD 0.17 0.16 0.14
SJL_HFD/SJL_SD 0.18 0.17 0.15
NZO_SD/SJL_SD 0.19 0.17 0.14
StDev log2 NZO_HFD/SJL_SD 0.25 0.22 0.20
SJL_HFD/SJL_SD 0.24 0.24 0.21
Experimental reproducibility using the analysis methods investigated (columns). For the 3 experimental ratios (NZO_SD/SJL_SD, NZO_HFD/SJL_SD and SJL_HFD/
SJL_SD) the mean coefficient of variation (CV) and the mean standard deviation for log2 quantitation ratios (see Methods) of all proteins are stated.
Mascot XTandem/OpenMS
PPINGUIN 302
23
9
45
93
9
24
99
Figure 3 Venn Diagram. Venn diagram visualizing the number of
significantly identified protein accessions using the three different
approaches: Mascot, XTandem/OpenMS and PPINGUIN. We refer to
protein accessions identified in all three experimental replications of
the diabetes dataset (see Methods).
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Page 6 of 12concentration for NZO_HF (117) while peptides in clus-
ter 4 show the opposite behavior. The peptides belonging
to each cluster are located in different sites of the protein.
As discussed below, this finding is a hint towards two
variants of the RS_30 protein.
For quantitative assessment of overall peptide profile
homogeneity we have performed a comprehensive statis-
tical evaluation. We calculated CV values for each of the
three approaches (see method section). We observed a
CV of peptides assigned to a protein of 20% for MAS-
COT and 26% for X!Tandem while PPINGUIN has a
smaller CV of 14%.
Reduced variance in PPINGUIN is an expected effect
since the peptides within each cluster are rather similar by
construction. For an independent assessment of our
method we now proceed to investigate experimental
reproducibility (precision) and accordance with prior
knowledge.
Peptide Quantitation Profiles
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Figure 4 Sample peptide profiles. Visualization of peptide quantitation profiles of the three different approaches employed (rows)
demonstrated for 3 exemplary chosen proteins (columns). The three rows correspond to the applied method: first row = MASCOT, second row
= X!Tandem and OpenMS, last row = PPINGUIN. Each individual plot shows ratio profiles of peptides uniquely assigned to the corresponding
protein. For every ratio a box plot giving the lower quartile, median and upper quartile is drawn.
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Page 7 of 12Precision - Experimental Reproducibility
In order to test reproducibility we performed three inde-
pendent experimental replications and three independent
evaluations (see Dataset section in Methods). We investi-
gated two different mouse genotypes and two diets
resulting in 4 distinct combinations. The 4 combinations
define 3 ratios using SJL genotype with standard diet
(SD) as reference. Quantitation ratios for a protein are
calculated by averaging the log ratios of the correspond-
ing peptides. To facilitate comparability we restrict the
analysis to the set of 99 proteins identified in all three
experimental replications.
We calculated mean coefficient of variation and mean
standard deviation of log quantitation ratios (CV and
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Figure 5 Ribosomal Proteins. Upper part: Quantitation profiles of the unique peptides assigned to the ribosomal protein RS30 detected in the
first experiment. Labels are representing the samples: 114 - NZO_SD; 115 - SJL_HF; 116 - SJL_SD and 117 - NZO_HF. Colors orange and blue
correspond to clusters 1 and 4 the peptides were identified in. Lower part: Protein sequence with positions of mapped peptides. Vertical bars
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Table 2).
The analysis was performed separately for each of the
3 experimental ratios: NZO_SD/SJL_SD, NZO_HFD/
SJL_SD and SJL_HFD/SJL_SD.
Experimental variation of the MASCOT based evalua-
tion is characterized by CV values ranging from 0.13 to
0.18 (see first column in Table 2). X!Tandem/OpenMS
results in CV values ranging from 0.12 to 0.17 (second
column in Table 2). Experimental variation is reduced
using PPINGUIN with CV values ranging from 0.10 to
0.15 (third column in Table 2).
Different from the improved homogeneity in the pre-
vious section, the lower error of PPINGUIN is not a trivial
effect since the complete analysis workflow is performed
for each experiment independently. These results demon-
strate that applying the proposed method for data evalua-
tion leads to more stable quantitation values.
Accordance with prior knowledge
The identification of differentially expressed proteins is a
major goal of quantitative proteomics. We now compare
the set of differentially expressed biomarker candidates
obtained with the three different methods. To assess the
results of the differential analysis, we use a set of ‘gold
standard’ genes identified in the context of type-2 dia-
betes [44]. This meta-analysis reports top gene candi-
dates for mixture of genotypic and dietary effects. To
achieve comparability with the meta-analysis, differential
analysis is performed comparing NZO mice with high
fat diet and SJL mouse with standard diet (see Dataset
section).
Top lists of differentially expressed proteins are cre-
ated by selecting proteins with mean absolute log2 fold
changes above arbitrarily chosen threshold of 0.5 (1.4
fold change). Due to the low number of replicates we
use the fold instead of the p-value as criterion to judge
differential expression.
Evaluation based on MASCOT identifies a total of 14
differentially regulated proteins of which 29% (4) are
found in the reference. Using X!Tandem and OpenMS
we identified only 8 differential proteins of which 37%
(3) are found if the reference set. PPINGUIN results in
14 differentially expressed proteins, of which 50% (7) are
part of the reference set. Table 3 presents the statistics
of the differentially regulated proteins identified using
PPINGUIN (proteins of the reference set are marked
with asterisks). Of the three methods, PPINGUIN shows
the highest agreement with the reference list. This
remains true for alterations of the threshold value (e.g.
0.3 or 0.7).
Discussion
Typically, data mining techniques are applied after pro-
tein inference and quantitation. In contrast to the stan-
dard workflow, our approach employs clustering prior
to protein inference as a very early step in data proces-
sing (see workflow comparison in Figure 2). Recently
different approaches have been proposed to improve
protein identification using peak intensities [26,45]. In
contrast to these works, our major goal is to improve
quantitation itself based on a set of proven and tested
identification tools.
A key feature of our approach is shown in Figure 5:
the separation of unique peptides for a protein in multi-
ple clusters. Non-unique peptides shared by different
proteins are not considered. The peptides in each clus-
ter exhibit distinct quantitation profiles which are most
Table 3 Accordance with prior knowledge
Protein ID Description log2 Fold P-Value #Peptides X!Tandem Score
Q9Z204 heterogeneous nuclear ribonucleoprotein C 1.21 0.158 2 2.8
O35490 betaine-homocysteine methyltransferase -0.979 0.00148 24 59.6
P33267 cytochrome P450, family 2, subfamily f* -0.857 0.131 3 10.1
P97872 flavin containing monooxygenase 5 -0.799 0.0425 3 10.6
Q91V92 ATP citrate lyase* 0.72 0.231 5 9.4
Q9Z2V4 phosphoenolpyruvate carboxykinase 1* -0.706 0.0782 2 6.8
Q8VCH0 acetyl-Coenzyme A acyltransferase 1B 0.693 0.0318 2 6.1
P10649 glutathione S-transferase, mu 1* -0.689 0.105 5 8.3
P01942 hemoglobin alpha, adult chain 1 0.678 0.359 16 16.2
P70694 aldo-keto reductase family 1* -0.634 0.0245 6 17.7
Q9CPY7 leucine aminopeptidase 3 -0.629 0.0926 4 17.5
Q8R0Y6 aldehyde dehydrogenase 1 family, member L1 -0.566 0.0747 5 15.6
P12710 fatty acid binding protein 1* 0.524 0.221 17 50.8
P53657 pyruvate kinase liver and red blood cell* 0.51 0.278 8 35.3
Top list of differentially regulated proteins identified using PPINGUIN. Proteins marked with an asterisk (*) have previously been associated with diabesity [44]. P-
values are calculated using one-sample t-test (null hypothesis: log2(NZO_HFD/SJL_SD) = 0). P-values are not used as a criterion for differential expression and are
not corrected for multiple testing. With an increasing number of replicates in future studies significance of the p-values may be improved.
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for isoforms are protein modification, splice variants or
degradation effects.
For further investigation of protein modifications, we
first identified most frequent modifications in our dataset.
For each of the 800 modifications listed in Unimod [46]
we re-performed protein inference searching for single
variable modifications. The most frequent modification
found was oxidation of methionine which increased the
number of found peptide-spectrum-matches by almost
10%. Oxidation of methionine, whose impact on iTRAQ
has been reported previously [47], can be caused by an
enzymatic reaction but can also be due to sample prepara-
tion in the presence of reactive oxygen species. Other fre-
quent modifications were ‘Oxidation (D)’, ‘Oxidation (N)’,
‘Deamidated (Q)’. Subsequently we re-performed the ana-
lysis allowing for these 4 variable modifications simulta-
neously. However, in this second identification step we did
not find further evidence for protein modification regard-
ing the RS_30 protein isoforms.
Investigating splice variants as a possible explanation,
we found that RS_30 protein is transcribed from exon 4
and 5 of the FAU (Ensembl-ID: ENSMUSG00000038274)
gene. The peptides from different clusters are located in
different regions of the protein which also correspond to
the different exons of the FAU gene, but there was no
indication for differential splicing in the database. How-
ever, the FAU gene may have two variants: the RS_30
protein with 59 amino acids and the completely tran-
scribed protein with 133 amino acids. PPINGUIN finds
t w ov a r i a n t so ft h eR S3 0g e n e .T h et w oi s o f o r m sf o u n d
by PPINGUIN may correspond to the two potential var-
iants, which of cause would require further experimental
investigations. But if PPINGUIN can detect potential
novel splice variants it may help to improve protein or
even nucleotide databases.
PPINGUIN is not designed to exploit known protein
variants, but it may indirectly re-detect also known var-
iants. Incorporating the knowledge of known protein var-
iants during protein inference, should further improve
protein quantitation.
The set of identified proteins is altered comparing
PPINGUIN and X!Tandem. Assignment of peptides to
different groups and subsequent protein identification for
each group individually, is expected to lower identifica-
tion significance and thus to reduce the number of pro-
teins. Indeed, a random grouping identifies only 138
(±10) proteins in all experiments. However, biologically
motivated clustering used by PPINGUIN, leads to a total
of 176 proteins, 32 of which are found only by PPIN-
GUIN and not by X!Tandem. This is due to two com-
bined effects: First, exploiting quantitation profile
information, our clustering leads to a relative enrichment
of peptides belonging to the same protein in a cluster
and second, by splitting spectra into groups, clustering
decreases the total number of spectra in each identifica-
tion process. The reduced number of spectra per cluster
alters the identification threshold used for calibration of
the false discovery rate and in effect new proteins are
identified. The largest set of uniquely identified proteins
was found for MASCOT. Most of these 93 unique MAS-
COT proteins are also found using X!Tandem but they
remain below the significance threshold. This is mostly
due to differences in the assessment of short peptides
since MASCOT appears to include many small peptides
for identification that are excluded by X!Tandem. The set
of quantified protein accessions received by PPINGUIN
is characterized by an increased experimental reproduci-
bility compared to the other methods. This implies that
using PPINGUIN for evaluation, one experimental out-
come is a more reliable predictor for the outcome of a
similar experiment. Finally, the comparison with prior
knowledge showed a surprisingly high agreement of our
top proteins with a reference set, which we deem repre-
sentative for diabetes and obesity. This hints for the prac-
tical benefit of our method.
Conclusion
We proposed a novel method for evaluation of iTRAQ
data motivated by the observation that relative concentra-
tions of peptides derived from the same protein often
show unexpectedly heterogeneous correlation patterns.
Exploiting correlations of quantitation ratios achieves
more consistent quantitation ratios than the standard
approaches. This is demonstrated by an increased repro-
ducibility of independent experiments. Besides leading to a
more reliable quantitation, the method can reveal new iso-
form candidates.
We see our work as a promising step towards quantita-
tion guided identification. In general, we recommend to
use our method in case accurate quantitation is a major
objective of research. Regarding the increasing importance
of quantitative proteomics we think that this method will
be useful in practical applications like model fitting or
functional enrichment analysis.
We expect that our approach will be still more valu-
able with an increasing number of parallel quantified
samples (e.g. 8-plex iTRAQ) since the importance of the
clustering increases. The proposed approach can also be
very useful for other quantitative proteomics technolo-
gies like e.g. SILAC. A next step will be to extend the
algorithms to include spectra with incomplete iTRAQ
quantitations. Future versions of PPINGUIN will aim at
further refinement of protein quantitation by incorpor-
ating the rapidly growing public knowledge on splice
variants and protein isoforms.
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Page 10 of 12Additional material
Additional file 1: R-script of PPINGUIN. PPINGUIN.R: R-script with our
implementation of PPINGUIN. The script requires OpenMS and X!Tandem
to be installed.
Additional file 2: Normalization - Results. More detailed description of
the normalization strategy applied in this work. The effects of the
normalization algorithms on channel bias and homoscedasticity are
demonstrated.
Additional file 3: Examples for Potential Isoforms. Additional zip
archive containing pdf images for 6 further examples with potential
protein isoforms.
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